Australia markets open in 3 hours 28 minutes

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.78-0.08 (-0.16%)
At close: 04:00PM EDT
50.75 -0.03 (-0.06%)
After hours: 04:29PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
37,200
31,900
64,392
35,952
42,875
Cost of revenue
1,310
302
-
-
-
Gross profit
35,890
31,598
-
-
-
Operating expenses
Research development
70,550
82,990
77,882
70,276
62,736
Selling general and administrative
97,081
78,851
42,186
24,155
20,409
Total operating expenses
167,551
161,517
119,569
94,255
83,145
Operating income or loss
-131,661
-129,919
-55,177
-58,303
-40,270
Interest expense
2,494
2,695
2,643
2,149
1,224
Total other income/expenses net
-
-1,836
-179
2,814
2,304
Income before tax
-133,094
-131,755
-55,356
-55,489
-37,966
Income from continuing operations
-133,094
-131,755
-55,356
-55,489
-37,966
Net income
-133,094
-131,755
-55,356
-55,489
-37,966
Net income available to common shareholders
-133,094
-131,755
-55,356
-55,489
-37,966
Basic EPS
-
-1.89
-0.84
-0.98
-0.76
Diluted EPS
-
-1.89
-0.84
-0.98
-0.76
Basic average shares
-
69,851
65,688
56,898
49,814
Diluted average shares
-
69,851
65,688
56,898
49,814
EBITDA
-
-125,921
-51,916
-51,698
-36,230